Novartis AG (NVS)
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
Novartis IgAN data in The Lancet show clinically meaningful slowing of kidney function decline with Vanrafia® over 2.5 years
INTU Alert: BFA Law Reminds Intuit Investors that Suffered Losses of its Pending Securities Fraud Investigation into 20% Stock Drop
Robo.ai Subsidiary Neurovia AI to Participate as Official Government Al Cybersecurity Partner at The 3rd Government Cybersecurity Summit
X-energy Reports First Quarter 2026 Results
Auddia Announces First Build Milestones for McCarthy Finney Operating System (MCFN-OS) Ahead of Proposed Merger Close
Ragnarok: Twilight Global Official Launching in Europe and North, Central and South America on June 4, 2026
FreeCast Signs Via One Affiliates, Assist Wireless and enTouch Wireless for Utilizing FreeCasts PaaS (Platform-as-a-Service)
DXC to Simplify and Strengthen Ifs Technology Estate Across the Nordics with DXC OASIS USA - English Sverige - Svenska
Form 8.3
DXC to Simplify and Strengthen Ifs Technology Estate Across the Nordics with DXC OASIS USA - English USA - English Sverige - Svenska